Submit Manuscript  

Article Details

Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus

[ Vol. 18 , Issue. 5 ]


Mohammad Reza Rahbar, Hadi Esmaeili Gouvarchin Galeh, Saeed Khalili and Abolfazl Jahangiri*   Pages 418 - 421 ( 4 )


The recent pandemic caused by a novel coronavirus known as SARS-CoV-2 has caught the international community by surprise. There is still no effective vaccine or treatment option against this virus. In this perspective, we discussed the potential protective and therapeutic effects of chitosan, as an FDA-approved biomolecule, against COVID-19 and influenza viruses.


Chitosan, COVID-19, immune response, innate Immunity, biotherapeutic, macromolecule.


Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Department of Biology Sciences, Shahid Rajaee Teacher Training University, Tehran, Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran

Read Full-Text article